439 TGF-beta2 suppression by the antisense oligonucleotide AP 12009 as therapy for high-grade glioma: safety and efficacy results of phase I/II clinical studies

✍ Scribed by K. Schlingensiepen; P. Hau; A. Brawanski; J. Schlaier; M. Mehdorn; G. Wurm; J. Pichler; M. Kunst; G. Stauder; U. Bogdahn

• Book ID: 118621622
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 293 KB
• Volume: 2
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(04)80447-6